JUN 02, 2017 9:31 AM PDT

Gut microbes and metformin team up

WRITTEN BY: Kerry Evans

Metformin is a drug that helps people with type 2 diabetes control their blood glucose level, but nobody really knows how it works.

 

There is evidence that metformin suppresses the hepatic output of glucose by altering the activity of AMPK-dependent and independent signaling pathways. However, some studies suggest that its glucose-lowering activity occurs in the bowel, and researchers at Sahlgrenska Academy knew that the microbiome is altered in people with diabetes.

 

Metformin alters the gut microbiome.

 

To determine how the microbiome is affected by metformin, they sequenced the microbiomes of 22 people with newly diagnosed diabetes - before and after they started taking metformin or a placebo. They also transferred human fecal samples to mice and studied the effects of these microbes on glucose metabolism.

 

First, the group performed whole-genome shotgun sequencing on fecal samples to characterize the microbiome. The abundance of only one type of bacteria changed in the placebo group, but metformin significantly altered the abundance of 86 strains after 4 months of treatment. The majority of these belonged to the γ-proteobacteria and Firmicutes. Specifically, metformin altered the abundance of Escherichia and Intestinibacter species.

 

Next, they investigated whether the metformin-altered microbiota had any effect on blood glucose. To do this, they transferred fecal samples from humans to germ-free mice and measured glucose tolerance. Mice that received fecal samples from people treated with metformin for 4 months (versus untreated) improved their glucose tolerance.

 

Not only did metformin alter the abundance of some groups of bacteria, it also altered bacterial gene expression. For example, metformin treatment increased the expression of genes for bacterial secretion systems, two-component systems, ATP-binding cassette transporters, chemotaxis, antimicrobial peptide resistance, LPS biosynthesis, and certain metabolic pathways.

 

Gut bacteria are known to produce short-chain fatty acids (SCFAs) and regulate bile acid metabolism. It’s possible that these activities could work with metformin to benefit the host. Male subjects who were treated with metformin for four months had higher concentrations of fecal propionate and butyrate (SCFAs). Metformin also increased the fecal concentrations of organic acids such as lactate and succinate. As for bile acids, metformin did not alter bile acid metabolism in the gut, but plasma bile acid concentrations did increase.

 

According to study author Fredrik Bäckhed, “imagine if we can change the intestinal flora in the future so that more people respond to treatment, and that adverse events can be reduced by changing the gut microbiota of patients who will take metformin.”

 

Sources: Nature Medicine, Science Daily

 

 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
NOV 27, 2019
Genetics & Genomics
NOV 27, 2019
Humans Are Continuing to Evolve, Along With Immune-Related Diseases
Humans have evolved in some ways to be less susceptible to pathogens, but those benefits can also carry risks of other diseases....
DEC 01, 2019
Genetics & Genomics
DEC 01, 2019
Engineering a Better Viral Delivery System for Gene Therapy
To send gene therapy to diseased cells, scientists have turned to adeno-associated viruses (AAVs) to act as a delivery system....
DEC 02, 2019
Microbiology
DEC 02, 2019
Understanding How a Superbug Spreads in the Home
Superbugs, which are pathogens that are resistant to the effects of antibiotics, are a rising threat to human health....
DEC 20, 2019
Neuroscience
DEC 20, 2019
Are Migraines Caused by Unhealthy Gut Bacteria?
Research is increasingly pointing towards the importance of the gut-brain axis in regulating our health. Not only has the health of our gut bacteria, or mi...
FEB 02, 2020
Microbiology
FEB 02, 2020
A Potential Treatment for MERS is Found
A coronavirus causes MERS, which currently has no treatment. This work may help change that....
FEB 11, 2020
Clinical & Molecular DX
FEB 11, 2020
Portable device turns smartphones into diagnostic labs
Your smartphone lets you connect with friends, stores your memories, sends work emails and pays for your groceries. Soon, it could even help diagnose if yo...
Loading Comments...